Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Cancer Survivorship
Published in: Journal of Cancer Survivorship 1/2015

01-03-2015

Mental health services utilization and expenditures associated with cancer survivorship in the United States

Authors: Chunyu Li, Chenghui Li, Laura Forsythe, Catherine Lerro, Anita Soni

Published in: Journal of Cancer Survivorship | Issue 1/2015

Login to get access

Abstract

Purpose

The aim of this study is to assess mental health services utilization and expenditures associated with cancer history using a nationally representative sample in the US.

Methods

We used data from the 2008–2011 Medical Expenditure Panel Survey and multivariate regression models to assess mental health services use and expenditures among cancer survivors compared to individuals without a cancer history, stratified by age (18–64 and ≥65 years) and time since diagnosis (≤1 vs. >1 year).

Results

Among adults aged 18–64, compared with individuals without a cancer history, cancer survivors were more likely to screen positive for current psychological distress and depression regardless of time since diagnosis; survivors diagnosed >1 year ago were more likely to use mental health prescription drugs; those diagnosed within 1 year reported significantly lower annual per capita mental health drug expenditure and out-of-pocket mental health expenditure, while those diagnosed >1 year presented significantly higher annual per capita mental health expenditure. No significant differences in mental health expenditures were found among adults aged 65 or older.

Conclusions

Mental health problems presented higher health and economic burden among younger and longer-term survivors than individuals without a cancer history. This study provides data for monitoring the impact of initiatives to enhance coverage and access for mental health services at the national level.

Implications for cancer survivors

Early detection and appropriate treatment of mental health problems may help improve quality of cancer survivorship.
Literature
1.
Adler N, Page A, eds. Cancer Care for the Whole Patient: meeting Psychosocial Healthcare Needs. Washington DC: Institute of Medicine (IOM). 2008.
2.
Hewitt M, Greenfield S, Stovell E, editors. From cancer patient to cancer survivor: lost in transition. Washington DC: National Academies Press; 2006.
3.
Holland J, Weiss T. The new standard of quality cancer care: integrating the psychosocial aspects in routine cancer from diagnosis through survivorship. Cancer J. 2008;14:425–8.CrossRefPubMed
4.
Findley PA, Sambamoorthi U. Preventive health services and lifestyle practices in cancer survivors: a population health investigation. J Cancer Surviv. 2009;3:43–58.CrossRefPubMed
5.
Butler L, Downe-Wamboldt B, Melanson P, et al. Prevalence, correlates, and costs of patients with poor adjustment to mixed cancers. Cancer Nurs. 2006;29:9–16.CrossRefPubMed
6.
7.
Satin JR, Linden W, Phillips MJ. Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer. 2009;115:5349–61.CrossRefPubMed
8.
Mols F, Husson O, Roukema JA, van de Poll-Franse LV. Depressive symptoms are a risk factor for all-cause mortality: results from a prospective population-based study among 3,080 cancer survivors from the PROFILES registry. J Cancer Surviv. 2013;7(3):484–92.CrossRefPubMed
9.
Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr. 2004;32:57–71.CrossRefPubMed
10.
Mitchell AJ, Chan M, Bhatti H, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12:160–74.CrossRefPubMed
11.
Earle CC, Neville BA, Fletcher R. Mental health service utilization among long-term cancer survivors. J Cancer Surviv. 2007;1:156–60.CrossRefPubMed
12.
Kaiser NC, Hartoonian N, Owen JE. Toward a cancer-specific model of psychological distress: population data from the 2003–2005 National Health Interview Surveys. J Cancer Surviv-Res Pract. 2010;4:291–302.CrossRef
13.
Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62:220–41.CrossRefPubMed
14.
15.
Pincus HA, Tanielian TL, Marcus SC, et al. Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties. JAMA. 1998;279:526–31.CrossRefPubMed
16.
Zuvekas SH. Trends in mental health services use and spending, 1987–1996. Health Aff (Millwood). 2001;20:214–24.CrossRef
17.
18.
Carlson LE, Bultz BD. Efficacy and medical cost offset of psychosocial interventions in cancer care: making the case for economic analyses. Psychooncology. 2004;13:837–49. discussion 850–836.CrossRefPubMed
19.
Gordon LG, Beesley VL, Scuffham PA. Evidence on the economic value of psychosocial interventions to alleviate anxiety and depression among cancer survivors: a systematic review. Asia Pac J Clin Oncol. 2011;7:96–105.CrossRefPubMed
20.
Hewitt M, Rowland JH. Mental health service use among adult cancer survivors: analyses of the National Health Interview Survey. J Clin Oncol. 2002;20:4581–90.CrossRefPubMed
21.
Punekar RS, Short PF, Moran JR. Use of psychotropic medications by US cancer survivors. Psychooncology. 2011; 10:1002/pon.2039.
22.
Zuvekas SH. Prescription drugs and the changing patterns of treatment for mental disorders, 1996–2001. Health Aff (Millwood). 2005;24:195–205.CrossRef
23.
24.
Mariotto AB, Yabroff KR, Shao Y, et al. Projections of the cost of cancer care in the United States: 2010–2020. J Natl Cancer Inst. 2011;103:117–28.PubMedCentralCrossRefPubMed
25.
26.
Helf M, Mahon SM, Eden KD, et al. Screening for skin cancer. Am J Pub Health. 2001;20(Supp1):47–58.
27.
Yabroff KR, Lawrence WF, Clauser S, et al. Burden of illness in cancer survivors: findings from a population-based national sample. J Natl Cancer Inst. 2004;96:1322–30.CrossRefPubMed
28.
Bradley CJ, Bednarek HL. Employment patterns of long-term cancer survivors. Psychooncology. 2002;11:188–98.CrossRefPubMed
29.
Hewitt M, Rowland JH, Yancik R. Cancer survivors in the United States: age, health, and disability. J Gerontol A Biol Sci Med Sci. 2003;58:82–91.CrossRefPubMed
30.
Brown ML, Riley GF, Schussler N, Etzioni R. Estimating health care costs related to cancer treatment from SEER-Medicare data. Med Care. 2002;40(8 Suppl):IV-104–17.
31.
Bradley CJ, Neumark D, Luo Z, Schenk M. Employment and cancer: findings from a longitudinal study of breast and prostate cancer survivors. Cancer Invest. 2007;25:47–54.CrossRefPubMed
32.
Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41:1284–92.CrossRefPubMed
33.
Kessler RC, Andrews G, Colpe LJ, et al. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol Med. 2002;32:959–76.CrossRefPubMed
34.
Manning, WG., Morris, CN, Newhouse, JP. A two-part model of the demand for medical care: preliminary results from the Health Insurance Study. In: van der Gaag, J., Perlman, M. (Eds.), Health, Economics, and Health Economics. North Holland, Amsterdam; 1981. p. 103–123.
35.
Manning WG, Basu A, Mullahy J. Generalized modeling approaches to risk adjustment of skewed outcomes data. J Health Econ. 2005;24:465–88.CrossRefPubMed
36.
37.
Hoffman KE, McCarthy EP, Recklitis CJ, et al. Psychological distress in long-term survivors of adult-onset cancer: results from a national survey. Arch Intern Med. 2009;169:1274–81.CrossRefPubMed
38.
Metadata
Title
Mental health services utilization and expenditures associated with cancer survivorship in the United States
Authors
Chunyu Li
Chenghui Li
Laura Forsythe
Catherine Lerro
Anita Soni
Publication date
01-03-2015
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 1/2015
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-014-0392-0

Other articles of this Issue 1/2015

Journal of Cancer Survivorship 1/2015 Go to the issue

OriginalPaper

Cost-effectiveness of cognitive behavioral therapy and physical exercise for alleviating treatment-induced menopausal symptoms in breast cancer patients

OriginalPaper

Identifying suicidal symptoms in prostate cancer survivors using brief self-report

OriginalPaper

Predictors of physical activity in colorectal cancer survivors after participation in a telephone-delivered multiple health behavior change intervention

OriginalPaper

Career readiness in adult survivors of childhood cancer: a report from the St. Jude Lifetime Cohort Study

OriginalPaper

Blood pressure, salivary cortisol, and inflammatory cytokine outcomes in senior female cancer survivors enrolled in a tai chi chih randomized controlled trial

OriginalPaper

Cancer survivors’ self-efficacy to self-manage in the year following primary treatment
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits